This paper reviews advances in epilepsy in recent years with an emphasis on therapeutics
and underlying mechanisms, including status epilepticus, drug and surgical treatments …

Valproic acid (VPA) is a well-established anticonvulsant drug discovered serendipitously
and marketed for the treatment of epilepsy, migraine, bipolar disorder and neuropathic pain …

Summary The Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT
XIV) took place in Madrid, Spain, on May 13‐16, 2018 and was attended by 168 delegates …

Summary The Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT
XIII) took place in Madrid, Spain, on June 26–29, 2016, and was attended by> 200 …

In recent years, chiral molecules (especially enantiomers) have occupied a significant place
in pharmaceutical industry and have played a prominent role in the development of new …

Abstract Since 1992, the Eilat Conferences have provided a forum for all stakeholders in the
epilepsy community to appraise the latest data on new antiepileptic drugs and emergency …

Introduction: Epilepsy is one of the most common neurological diseases affecting
approximately 50 million people worldwide. Despite many advances in epilepsy research …

Recent advances in status epilepticus : Current Opinion in Neurology Recent advances in
status epilepticus : Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe …

Purpose Rescue medications for status epilepticus (SE) have a relatively high rate of failure.
The purpose of this review is to summarize the evidence for the efficacy of novel drugs and …

Opinion statement Convulsive status epilepticus (CSE) is a medical emergency with an
associated high mortality and morbidity. It is defined as a convulsive seizure lasting more …